Tag Archives: 2018

It is the last day of Bio 2018 and I am attending a curiously titled session:  Is Biotechnology Drowning in Health Related Data?   The panel’s answer to that question is “no” — in fact, they all agreed there isn’t enough data yet, if we want to achieve “convergence”.  That’s the new buzz word:  convergence.  One speaker described it as “a better quantification of humanity.” … More

It took three days, but I finally found a panel at BIO 2018 that addressed the current challenges in privacy and security regarding health data.  This panel, Realizing the Potential of Clinical and Consumer Genomics, was focused on all the new genetic tests that are available (with more to come) and all the genetic data those tests are generating.  I was particularly impressed with the approach of Mindstrong Health to privacy and security,… More

The late rapper known as The Notorious B.I.G. recorded a song called, “Mo Money, Mo Problems.”  Many of the lyrics can’t be repeated here, but the refrain can:

“It’s like the more money we come across
The more problems we see.”

This refrain came to mind yesterday as I sat in the BIO 2018 session about digital health:  A Look to the Future: Investors Corner –… More

I am attending BIO 2018 in Boston, just steps from our Boston office. Naturally, I was drawn to yesterday’s session on “Life Sciences Cyber Exposures and Risk Mitigation Considerations.” But I came away disappointed. First of all, the session was held in a small room and even then, it was only one-third full (maybe 30 people of the 16,000 attending BIO 2018 chose to attend).… More